Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Sang-Jae Park, National Cancer Center, Korea
Sponsor:
Information provided by (Responsible Party):
Sang-Jae Park, National Cancer Center, Korea
ClinicalTrials.gov Identifier:
NCT01333124
First received: April 1, 2011
Last updated: September 20, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)